Report Overview
Global Continuous Bladder Irrigation Devices Market size is expected to be worth around US$ 2.3 Billion by 2035 from US$ 1.5 Billion in 2025, growing at a CAGR of 4.5% during the forecast period from 2026 to 2035. In 2025, North America led the market, achieving over 41.5% share with a revenue of US$ 0.6 Billion.
The Continuous Bladder Irrigation (CBI) Device is an advanced medical solution designed to provide uninterrupted irrigation of the urinary bladder, primarily following urological surgeries and in the management of conditions associated with hematuria (blood in the urine). The device helps prevent clot formation, maintains catheter patency, and supports effective bladder drainage, contributing to improved patient outcomes and reduced complications.
Engineered for reliability and ease of use, the CBI Device delivers a controlled flow of sterile irrigation fluid into the bladder while facilitating continuous drainage through a closed-loop system. This process assists healthcare professionals in maintaining optimal bladder function and monitoring postoperative recovery efficiently.
The device features user-friendly controls, durable construction, and compatibility with standard urinary catheter systems, making it suitable for hospitals, surgical centers, and long-term care facilities. Its design prioritizes patient comfort, infection control, and workflow efficiency for healthcare providers.
With the growing demand for advanced urological care solutions, the Continuous Bladder Irrigation Device addresses critical clinical needs by supporting safe, consistent, and effective bladder management. The technology reflects ongoing innovation in medical device development, helping healthcare institutions enhance quality of care while promoting patient safety and recovery.
The Continuous Bladder Irrigation Device represents a valuable addition to modern urology practices, delivering dependable performance in diverse clinical environments.
Click here for more information: https://market.us/report/continuous-bladder-irrigation-devices-market/
Key Takeaways
M
- arket Size: Global Continuous Bladder Irrigation Devices Market size is expected to be worth around US$ 2.3 Billion by 2035 from US$ 1.5 Billion in 2025.
- Market Share: The market growing at a CAGR of 4.5% during the forecast period from 2026 to 2035.
- Product Type Analysis: the CBI Kits segment accounted for the largest market share of 44.6% in 2025.
- Material Analysis: The Silicone segment dominated the market with a 49.2% share in 2025
- Application Analysis: The Bladder Surgery segment held the leading market share of 33.8% in 2025
- End User Analysis: Hospitals dominated the market with a 58.6% share in 2025
- Regional Analysis: In 2025, North America led the market, achieving over 41.5% share with a revenue of US$ 0.6 Billion.
Key Market Segments
By Product Type
CBI Kits
CBI Catheters
CBI Tubing Sets
Others
By Material
Silicone
Latex
Plastic
By Application
Post-Prostatectomy
Bladder Surgery
Hematuria Management
Urinary Tract Infections
Others
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
Others
Becton, Dickinson and Company
Coloplast Group
Boston Scientific Corporation
Teleflex Incorporated
Medline Industries, Inc.
B. Braun Melsungen AG
Hollister Incorporated
Convatec Group PLC
Cook Medical
Rochester Medical Corporation
UROMED
Richard Wolf GmbH
Coopersurgical, Inc.
Urotech Devices
Porer Medical Corporation
Others
Driver
The increasing prevalence of urological disorders and surgical procedures is a major driver for the Continuous Bladder Irrigation (CBI) Devices Market. CBI devices are commonly used after transurethral resection of the prostate (TURP), bladder tumor surgeries, and management of severe hematuria to prevent clot formation and maintain urinary drainage. The growing aging population is contributing significantly to the demand for such procedures. According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), benign prostatic hyperplasia (BPH) affects approximately 5–6% of men aged 40–64 years and nearly 29–33% of men aged 65 years and older. Additionally, bladder cancer remains one of the most common urological cancers requiring postoperative bladder management. As surgical interventions increase, healthcare facilities are placing greater emphasis on effective postoperative care to reduce complications. Continuous bladder irrigation helps maintain catheter patency and supports patient recovery. The rising burden of age-related urinary disorders, combined with growing surgical volumes in hospitals and specialty urology centers, is therefore creating sustained demand for advanced CBI devices across developed and emerging healthcare systems.
Trend
A notable trend in the Continuous Bladder Irrigation Devices Market is the growing focus on infection prevention and closed urinary drainage systems. Healthcare providers are increasingly adopting devices designed to minimize contamination risks, improve patient monitoring, and support hospital infection-control initiatives. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 15–25% of hospitalized patients receive urinary catheters during their stay, and about 75% of hospital-acquired urinary tract infections are associated with urinary catheter use. These statistics have encouraged hospitals to implement stricter catheter management protocols and invest in technologies that support safer urinary drainage practices. Modern CBI systems are being developed with enhanced flow control, sterile irrigation pathways, and integrated monitoring features that help clinicians detect blockages and maintain consistent irrigation. Another emerging trend is the increasing adoption of disposable and single-use components to reduce cross-contamination risks. As healthcare facilities continue to prioritize patient safety and infection reduction targets, manufacturers are focusing on product innovations that align with clinical guidelines and hospital quality-improvement programs, thereby shaping the future direction of the CBI devices market.
Restraint
The risk of catheter-associated complications and stringent infection-control requirements remain significant restraints for the Continuous Bladder Irrigation Devices Market. Although CBI devices play an essential role in postoperative urological care, their use depends on indwelling urinary catheters, which can increase the risk of catheter-associated urinary tract infections (CAUTIs) when not managed properly. The CDC identifies CAUTIs as one of the most common healthcare-associated infections and reports that urinary tract infections account for more than 30% of infections reported by acute-care hospitals. Furthermore, prolonged catheterization is a recognized risk factor for infection development. Hospitals are therefore under increasing pressure to reduce catheter usage duration and adopt alternative management approaches whenever clinically feasible. Additional challenges include the need for trained healthcare personnel to monitor irrigation flow, manage complications, and maintain sterile procedures. In resource-constrained healthcare settings, the costs associated with infection prevention protocols, staff training, and device maintenance can further limit adoption. These operational and clinical concerns may slow market expansion, particularly in facilities with limited urology infrastructure or lower procedural volumes.
Opportunity
A significant opportunity for the Continuous Bladder Irrigation Devices Market lies in expanding healthcare infrastructure and the growing emphasis on reducing hospital-acquired infections through advanced urinary management technologies. Healthcare systems worldwide are investing in patient-safety initiatives and postoperative care improvements. According to CDC healthcare-associated infection data, approximately one in 31 hospital patients has at least one healthcare-associated infection on any given day. In 2024, 3,782 U.S. acute-care hospitals reported catheter-associated urinary tract infection surveillance data, highlighting the widespread focus on urinary catheter management and infection prevention. As hospitals seek to improve clinical outcomes and comply with quality standards, demand is expected to rise for advanced CBI systems featuring automated flow regulation, closed-loop irrigation, and enhanced monitoring capabilities. Emerging economies also present substantial opportunities due to increasing access to urological surgery, expanding hospital networks, and rising healthcare expenditure. Furthermore, technological integration with digital monitoring platforms can help clinicians track irrigation effectiveness and detect complications earlier. Companies that develop user-friendly, infection-resistant, and cost-effective CBI solutions are well positioned to benefit from healthcare modernization efforts and the growing global demand for safer postoperative urological care.
Conclusion
The global Continuous Bladder Irrigation Devices Market is poised for steady growth, driven by the increasing prevalence of urological disorders, rising surgical volumes, and growing demand for effective postoperative bladder management. Advancements in infection-control technologies, closed-loop irrigation systems, and patient monitoring capabilities are further supporting market expansion. While concerns regarding catheter-associated complications and the need for skilled clinical management may limit adoption in certain settings, ongoing healthcare investments and expanding hospital infrastructure create significant growth opportunities. With North America maintaining a leading position and emerging economies enhancing access to urological care, manufacturers are expected to focus on innovative, patient-centric, and infection-resistant solutions. As healthcare systems prioritize safety, efficiency, and improved clinical outcomes, Continuous Bladder Irrigation Devices will remain an essential component of modern urological treatment and postoperative care worldwide.
Conclusion: The global Continuous Bladder Irrigation Devices Market is poised for steady growth, driven by the increasing prevalence of urological disorders, rising surgical volumes, and growing demand for effective postoperative bladder management. Advancements in infection-control technologies, closed-loop irrigation systems, and patient monitoring capabilities are further supporting market expansion. While concerns regarding catheter-associated complications and the need for skilled clinical management may limit adoption in certain settings, ongoing healthcare investments and expanding hospital infrastructure create significant growth opportunities. With North America maintaining a leading position and emerging economies enhancing access to urological care, manufacturers are expected to focus on innovative, patient-centric, and infection-resistant solutions. As healthcare systems prioritize safety, efficiency, and improved clinical outcomes, Continuous Bladder Irrigation Devices will remain an essential component of modern urological treatment and postoperative care worldwide.
Top comments (0)